Finance

Lists
RCE:ASX
Recce Pharmaceuticals Ltd
A$0.36
-4.05%
(-0.015) 1D
Sep 11, 4:00:00 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RCE...
Open
A$0.37
High
A$0.37
Low
A$0.36
Mkt. cap
107.04M
Avg. vol.
68.98K
Volume
40.38K
52-wk high
A$0.73
52-wk low
A$0.34
EPS
-A$0.05
Shares outstanding
305.77M
Open
A$0.37
High
A$0.37
Low
A$0.36
Mkt. cap
107.04M
Avg. vol.
68.98K
Volume
40.38K
52-wk high
A$0.73
52-wk low
A$0.34
EPS
-A$0.05
Shares outstanding
305.77M
About Recce Pharmaceuticals Ltd
CEOJames Graham
Employees-
FoundedApr 11, 2007
Headquarters-
SectorPharmaceutical industry
Websiterecce.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
206.02K
206.02K
4.53M
4.53M
Cost of goods sold
5.05M
5.05M
-937.16K
-937.16K
Cost of revenue
5.05M
5.05M
-937.16K
-937.16K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.39M
2.39M
1.50M
1.50M
Operating expense
3.01M
3.01M
4.54M
4.54M
Total operating expenses
8.06M
8.06M
3.60M
3.60M
Operating income
-7.86M
-7.86M
924.89K
924.89K
Other non operating income
-
-
-29.89K
-29.89K
EBT including unusual items
-8.28M
-8.28M
799.15K
799.15K
EBT excluding unusual items
-8.28M
-8.28M
799.15K
799.15K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
207.15K
207.15K
2.75M
2.75M
Net income
-8.28M
-8.28M
799.15K
799.15K
Net profit margin
-4,018.96%
-4,018.96%
17.65%
17.65%
Earnings per share
-
-
-
-
Interest and investment income
20.36K
20.36K
33.92K
33.92K
Interest expense
-443.69K
-443.69K
-355.79K
-355.79K
Net interest expenses
-423.33K
-423.33K
-321.87K
-321.87K
Depreciation and amortization charges
33.52K
33.52K
144.68K
144.68K
EBITDA
-7.82M
-7.82M
925.94K
925.94K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps